nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprenolol—ADRB2—autistic disorder	0.788	1	CbGaD
Alprenolol—HTR1A—telencephalic ventricle—autistic disorder	0.00604	0.19	CbGeAlD
Alprenolol—HTR1A—hindbrain—autistic disorder	0.00285	0.0897	CbGeAlD
Alprenolol—ADRB1—forebrain—autistic disorder	0.00184	0.0579	CbGeAlD
Alprenolol—ADRB1—telencephalon—autistic disorder	0.00169	0.0532	CbGeAlD
Alprenolol—HTR1A—brainstem—autistic disorder	0.00164	0.0514	CbGeAlD
Alprenolol—HTR1A—forebrain—autistic disorder	0.00158	0.0496	CbGeAlD
Alprenolol—CYP2D6—hindbrain—autistic disorder	0.00155	0.0487	CbGeAlD
Alprenolol—HTR1A—telencephalon—autistic disorder	0.00145	0.0456	CbGeAlD
Alprenolol—Metipranolol—ADRB2—autistic disorder	0.00108	0.11	CrCbGaD
Alprenolol—ADRB1—head—autistic disorder	0.00105	0.0331	CbGeAlD
Alprenolol—Penbutolol—HTR1B—autistic disorder	0.001	0.102	CrCbGaD
Alprenolol—ADRB1—nervous system—autistic disorder	0.000999	0.0314	CbGeAlD
Alprenolol—ADRB1—central nervous system—autistic disorder	0.000962	0.0302	CbGeAlD
Alprenolol—HTR1A—head—autistic disorder	0.000904	0.0284	CbGeAlD
Alprenolol—CYP2D6—brainstem—autistic disorder	0.000888	0.0279	CbGeAlD
Alprenolol—CYP2D6—forebrain—autistic disorder	0.000857	0.0269	CbGeAlD
Alprenolol—HTR1A—nervous system—autistic disorder	0.000857	0.0269	CbGeAlD
Alprenolol—Esmolol—ADRB2—autistic disorder	0.000856	0.0872	CrCbGaD
Alprenolol—HTR1A—central nervous system—autistic disorder	0.000825	0.0259	CbGeAlD
Alprenolol—HTR1A—cerebellum—autistic disorder	0.000806	0.0254	CbGeAlD
Alprenolol—CYP2D6—telencephalon—autistic disorder	0.000788	0.0248	CbGeAlD
Alprenolol—ADRB1—brain—autistic disorder	0.000764	0.024	CbGeAlD
Alprenolol—Betaxolol—ADRB2—autistic disorder	0.000753	0.0768	CrCbGaD
Alprenolol—Penbutolol—ADRB2—autistic disorder	0.000747	0.0761	CrCbGaD
Alprenolol—Atenolol—ADRB2—autistic disorder	0.000747	0.0761	CrCbGaD
Alprenolol—Bisoprolol—ADRB2—autistic disorder	0.000728	0.0741	CrCbGaD
Alprenolol—Pindolol—HTR1B—autistic disorder	0.000724	0.0737	CrCbGaD
Alprenolol—Acebutolol—ADRB2—autistic disorder	0.000689	0.0702	CrCbGaD
Alprenolol—Oxprenolol—ADRB2—autistic disorder	0.000684	0.0697	CrCbGaD
Alprenolol—HTR1A—brain—autistic disorder	0.000655	0.0206	CbGeAlD
Alprenolol—CYP2D6—digestive system—autistic disorder	0.000601	0.0189	CbGeAlD
Alprenolol—Metoprolol—ADRB2—autistic disorder	0.000582	0.0593	CrCbGaD
Alprenolol—Pindolol—ADRB2—autistic disorder	0.000538	0.0548	CrCbGaD
Alprenolol—CYP2D6—head—autistic disorder	0.000491	0.0154	CbGeAlD
Alprenolol—CYP2D6—nervous system—autistic disorder	0.000465	0.0146	CbGeAlD
Alprenolol—CYP2D6—central nervous system—autistic disorder	0.000448	0.0141	CbGeAlD
Alprenolol—CYP2D6—cerebellum—autistic disorder	0.000438	0.0138	CbGeAlD
Alprenolol—Propranolol—HTR1B—autistic disorder	0.000395	0.0402	CrCbGaD
Alprenolol—CYP2D6—brain—autistic disorder	0.000356	0.0112	CbGeAlD
Alprenolol—Propranolol—ADRB2—autistic disorder	0.000294	0.0299	CrCbGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—IL6—autistic disorder	5.01e-05	0.000294	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—POMC—autistic disorder	5e-05	0.000293	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—IL5—autistic disorder	4.99e-05	0.000293	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—PRKCB—autistic disorder	4.99e-05	0.000293	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—WNT2—autistic disorder	4.97e-05	0.000292	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PDE4A—autistic disorder	4.94e-05	0.000289	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CALCA—autistic disorder	4.93e-05	0.000289	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GHR—autistic disorder	4.9e-05	0.000287	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—EXT1—autistic disorder	4.88e-05	0.000286	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—SLC6A8—autistic disorder	4.88e-05	0.000286	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PDE4A—autistic disorder	4.83e-05	0.000283	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—PIK3CG—autistic disorder	4.77e-05	0.00028	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—ADRB2—autistic disorder	4.76e-05	0.000279	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—AVPR1A—autistic disorder	4.72e-05	0.000277	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—DAO—autistic disorder	4.65e-05	0.000273	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—AVPR1A—autistic disorder	4.62e-05	0.000271	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—VIP—autistic disorder	4.56e-05	0.000268	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—GRM5—autistic disorder	4.56e-05	0.000268	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—ADRB2—autistic disorder	4.55e-05	0.000267	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—POMC—autistic disorder	4.54e-05	0.000266	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PRL—autistic disorder	4.53e-05	0.000266	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—AVPR1A—autistic disorder	4.52e-05	0.000265	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—AVP—autistic disorder	4.47e-05	0.000262	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—GRM5—autistic disorder	4.46e-05	0.000262	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—VIP—autistic disorder	4.46e-05	0.000262	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—UPB1—autistic disorder	4.46e-05	0.000262	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—OXTR—autistic disorder	4.42e-05	0.000259	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—SCT—autistic disorder	4.37e-05	0.000257	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—AVP—autistic disorder	4.37e-05	0.000256	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—VIP—autistic disorder	4.36e-05	0.000256	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GRM5—autistic disorder	4.36e-05	0.000256	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—OXTR—autistic disorder	4.32e-05	0.000254	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—ADRB2—autistic disorder	4.32e-05	0.000253	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—ADRB2—autistic disorder	4.3e-05	0.000252	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—SCT—autistic disorder	4.28e-05	0.000251	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—AVP—autistic disorder	4.27e-05	0.000251	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—OXTR—autistic disorder	4.23e-05	0.000248	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—SCT—autistic disorder	4.18e-05	0.000245	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ADM—autistic disorder	4.17e-05	0.000245	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—GABBR1—autistic disorder	4.17e-05	0.000245	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ASMT—autistic disorder	4.15e-05	0.000243	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GSTM5—autistic disorder	4.15e-05	0.000243	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—ADRB2—autistic disorder	4.13e-05	0.000242	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—EIF4E—autistic disorder	4.1e-05	0.000241	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—GABBR1—autistic disorder	4.08e-05	0.000239	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—ADM—autistic disorder	4.08e-05	0.000239	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PDE4B—autistic disorder	4.07e-05	0.000239	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—AVP—autistic disorder	4.06e-05	0.000238	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—AVP—autistic disorder	4.04e-05	0.000237	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IGF2—autistic disorder	4.02e-05	0.000236	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—EIF4E—autistic disorder	4.01e-05	0.000235	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GABBR1—autistic disorder	3.99e-05	0.000234	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ADM—autistic disorder	3.99e-05	0.000234	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PDE4B—autistic disorder	3.98e-05	0.000233	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—AVP—autistic disorder	3.97e-05	0.000233	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—OPRM1—autistic disorder	3.94e-05	0.000231	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—EIF4E—autistic disorder	3.92e-05	0.00023	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—SLC25A12—autistic disorder	3.9e-05	0.000229	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PDE4B—autistic disorder	3.89e-05	0.000228	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—AVP—autistic disorder	3.88e-05	0.000228	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—OPRM1—autistic disorder	3.85e-05	0.000226	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—PLA2G4A—autistic disorder	3.81e-05	0.000224	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PLA2G4A—autistic disorder	3.8e-05	0.000223	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—SLC19A1—autistic disorder	3.79e-05	0.000223	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—OPRM1—autistic disorder	3.77e-05	0.000221	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—PLA2G4A—autistic disorder	3.73e-05	0.000219	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—HTR2A—autistic disorder	3.72e-05	0.000218	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—IL2—autistic disorder	3.7e-05	0.000217	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MEF2C—autistic disorder	3.69e-05	0.000217	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—PLA2G4A—autistic disorder	3.65e-05	0.000214	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—HTR2A—autistic disorder	3.64e-05	0.000213	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—GZMB—autistic disorder	3.6e-05	0.000211	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—ITGB3—autistic disorder	3.6e-05	0.000211	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—HTR2A—autistic disorder	3.56e-05	0.000209	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—GZMB—autistic disorder	3.52e-05	0.000207	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HTR1B—autistic disorder	3.5e-05	0.000205	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—OXT—autistic disorder	3.5e-05	0.000205	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GZMB—autistic disorder	3.45e-05	0.000202	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HTR1B—autistic disorder	3.42e-05	0.000201	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—OXT—autistic disorder	3.42e-05	0.000201	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ADSL—autistic disorder	3.38e-05	0.000198	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—HTR2A—autistic disorder	3.38e-05	0.000198	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—HTR2A—autistic disorder	3.36e-05	0.000197	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—IL2—autistic disorder	3.36e-05	0.000197	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—OXT—autistic disorder	3.34e-05	0.000196	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HTR1B—autistic disorder	3.34e-05	0.000196	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—XDH—autistic disorder	3.32e-05	0.000195	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—HTR2A—autistic disorder	3.3e-05	0.000194	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—PRKCB—autistic disorder	3.26e-05	0.000191	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—STX1A—autistic disorder	3.26e-05	0.000191	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—NPAS2—autistic disorder	3.26e-05	0.000191	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TSC1—autistic disorder	3.25e-05	0.000191	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—DRD1—autistic disorder	3.25e-05	0.000191	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—HTR2A—autistic disorder	3.23e-05	0.000189	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TSC2—autistic disorder	3.19e-05	0.000187	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—PRKCB—autistic disorder	3.19e-05	0.000187	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—DRD1—autistic disorder	3.18e-05	0.000187	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TSC1—autistic disorder	3.18e-05	0.000187	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NTRK2—autistic disorder	3.16e-05	0.000186	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—DRD3—autistic disorder	3.15e-05	0.000185	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—TCN2—autistic disorder	3.14e-05	0.000184	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—LEP—autistic disorder	3.12e-05	0.000183	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—APOE—autistic disorder	3.12e-05	0.000183	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—PIK3CG—autistic disorder	3.12e-05	0.000183	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—PRKCB—autistic disorder	3.12e-05	0.000183	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TSC1—autistic disorder	3.11e-05	0.000182	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—DRD1—autistic disorder	3.11e-05	0.000182	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NTRK2—autistic disorder	3.09e-05	0.000181	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IL5—autistic disorder	3.08e-05	0.000181	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—DRD3—autistic disorder	3.08e-05	0.000181	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—PIK3CG—autistic disorder	3.05e-05	0.000179	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CALCA—autistic disorder	3.04e-05	0.000179	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NTRK2—autistic disorder	3.03e-05	0.000177	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IL5—autistic disorder	3.01e-05	0.000177	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—DRD3—autistic disorder	3.01e-05	0.000177	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ADA—autistic disorder	3e-05	0.000176	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—PIK3CG—autistic disorder	2.98e-05	0.000175	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CALCA—autistic disorder	2.98e-05	0.000175	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—POMC—autistic disorder	2.97e-05	0.000174	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—PRKCB—autistic disorder	2.96e-05	0.000174	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IL5—autistic disorder	2.95e-05	0.000173	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PRKCB—autistic disorder	2.95e-05	0.000173	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CALCA—autistic disorder	2.91e-05	0.000171	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—POMC—autistic disorder	2.9e-05	0.00017	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—PRKCB—autistic disorder	2.9e-05	0.00017	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—POMC—autistic disorder	2.84e-05	0.000167	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—PIK3CG—autistic disorder	2.83e-05	0.000166	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—PRKCB—autistic disorder	2.83e-05	0.000166	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—APC—autistic disorder	2.82e-05	0.000165	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PIK3CG—autistic disorder	2.82e-05	0.000165	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—EGF—autistic disorder	2.79e-05	0.000163	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—PIK3CG—autistic disorder	2.77e-05	0.000163	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—RORA—autistic disorder	2.73e-05	0.00016	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—PIK3CG—autistic disorder	2.71e-05	0.000159	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—POMC—autistic disorder	2.7e-05	0.000158	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PRL—autistic disorder	2.69e-05	0.000158	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—POMC—autistic disorder	2.68e-05	0.000157	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—POMC—autistic disorder	2.64e-05	0.000155	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PRL—autistic disorder	2.63e-05	0.000154	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IGF1—autistic disorder	2.58e-05	0.000151	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—POMC—autistic disorder	2.58e-05	0.000151	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PRL—autistic disorder	2.57e-05	0.000151	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—MAPK1—autistic disorder	2.57e-05	0.000151	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—MAOB—autistic disorder	2.56e-05	0.00015	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ADRB2—autistic disorder	2.55e-05	0.00015	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—SERPINE1—autistic disorder	2.45e-05	0.000144	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ADRB2—autistic disorder	2.44e-05	0.000143	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—AVP—autistic disorder	2.4e-05	0.000141	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IGF2—autistic disorder	2.39e-05	0.00014	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—TPH2—autistic disorder	2.38e-05	0.00014	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—AVP—autistic disorder	2.34e-05	0.000138	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—DPYD—autistic disorder	2.34e-05	0.000137	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IGF2—autistic disorder	2.33e-05	0.000137	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—AVP—autistic disorder	2.29e-05	0.000134	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IGF2—autistic disorder	2.28e-05	0.000134	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PLA2G4A—autistic disorder	2.25e-05	0.000132	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PLA2G4A—autistic disorder	2.2e-05	0.000129	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—IL2—autistic disorder	2.19e-05	0.000129	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MEF2C—autistic disorder	2.19e-05	0.000129	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CACNA1C—autistic disorder	2.18e-05	0.000128	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PLA2G4A—autistic disorder	2.16e-05	0.000126	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—IL2—autistic disorder	2.15e-05	0.000126	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MEF2C—autistic disorder	2.14e-05	0.000126	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ITGB3—autistic disorder	2.14e-05	0.000125	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—IL2—autistic disorder	2.1e-05	0.000123	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MEF2C—autistic disorder	2.1e-05	0.000123	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—ITGB3—autistic disorder	2.09e-05	0.000123	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—HRAS—autistic disorder	2.06e-05	0.000121	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ITGB3—autistic disorder	2.04e-05	0.00012	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HTR2A—autistic disorder	1.99e-05	0.000117	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—IL2—autistic disorder	1.99e-05	0.000117	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IL2—autistic disorder	1.98e-05	0.000116	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—DHFR—autistic disorder	1.98e-05	0.000116	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—IL6—autistic disorder	1.97e-05	0.000116	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HTR2A—autistic disorder	1.95e-05	0.000114	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—IL2—autistic disorder	1.95e-05	0.000114	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HTR2A—autistic disorder	1.91e-05	0.000112	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—IL2—autistic disorder	1.91e-05	0.000112	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TSC2—autistic disorder	1.89e-05	0.000111	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PTEN—autistic disorder	1.87e-05	0.000109	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—LEP—autistic disorder	1.85e-05	0.000109	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—APOE—autistic disorder	1.85e-05	0.000109	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TSC2—autistic disorder	1.85e-05	0.000109	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—LEP—autistic disorder	1.81e-05	0.000106	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—APOE—autistic disorder	1.81e-05	0.000106	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TSC2—autistic disorder	1.81e-05	0.000106	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—APOE—autistic disorder	1.77e-05	0.000104	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—LEP—autistic disorder	1.77e-05	0.000104	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PRKCB—autistic disorder	1.75e-05	0.000103	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PRKCB—autistic disorder	1.71e-05	0.0001	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—APC—autistic disorder	1.67e-05	9.82e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PIK3CG—autistic disorder	1.67e-05	9.82e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PRKCB—autistic disorder	1.67e-05	9.81e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—EGF—autistic disorder	1.65e-05	9.7e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PIK3CG—autistic disorder	1.64e-05	9.6e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—APC—autistic disorder	1.64e-05	9.6e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—EGF—autistic disorder	1.62e-05	9.49e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PIK3CG—autistic disorder	1.6e-05	9.39e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—APC—autistic disorder	1.6e-05	9.39e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—POMC—autistic disorder	1.59e-05	9.34e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—EGF—autistic disorder	1.58e-05	9.28e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—POMC—autistic disorder	1.56e-05	9.14e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CYP19A1—autistic disorder	1.55e-05	9.11e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IGF1—autistic disorder	1.53e-05	8.99e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—MAPK1—autistic disorder	1.52e-05	8.94e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—POMC—autistic disorder	1.52e-05	8.94e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MAPK1—autistic disorder	1.52e-05	8.9e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IGF1—autistic disorder	1.5e-05	8.79e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—MAPK1—autistic disorder	1.49e-05	8.75e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IGF1—autistic disorder	1.47e-05	8.6e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—MAPK1—autistic disorder	1.46e-05	8.56e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—SERPINE1—autistic disorder	1.45e-05	8.53e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—COMT—autistic disorder	1.44e-05	8.47e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GSTP1—autistic disorder	1.44e-05	8.43e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—MAOA—autistic disorder	1.43e-05	8.41e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—SERPINE1—autistic disorder	1.42e-05	8.35e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CAT—autistic disorder	1.4e-05	8.2e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—SERPINE1—autistic disorder	1.39e-05	8.16e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GSTM1—autistic disorder	1.32e-05	7.74e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PLA2G4A—autistic disorder	1.32e-05	7.74e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GPX1—autistic disorder	1.26e-05	7.42e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—HRAS—autistic disorder	1.22e-05	7.18e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—HRAS—autistic disorder	1.22e-05	7.15e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—HRAS—autistic disorder	1.2e-05	7.02e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IL2—autistic disorder	1.18e-05	6.91e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—IL6—autistic disorder	1.17e-05	6.87e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—HRAS—autistic disorder	1.17e-05	6.87e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—MTHFR—autistic disorder	1.17e-05	6.84e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IL6—autistic disorder	1.17e-05	6.84e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IL2—autistic disorder	1.15e-05	6.76e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—IL6—autistic disorder	1.15e-05	6.72e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IL2—autistic disorder	1.13e-05	6.61e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—IL6—autistic disorder	1.12e-05	6.57e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PTEN—autistic disorder	1.11e-05	6.5e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—APOE—autistic disorder	1.09e-05	6.37e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PTEN—autistic disorder	1.08e-05	6.36e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PTEN—autistic disorder	1.06e-05	6.22e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PIK3CG—autistic disorder	9.8e-06	5.75e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—POMC—autistic disorder	9.33e-06	5.47e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MAPK1—autistic disorder	9.01e-06	5.28e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MAPK1—autistic disorder	8.81e-06	5.17e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MAPK1—autistic disorder	8.62e-06	5.05e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PTGS2—autistic disorder	7.44e-06	4.37e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HRAS—autistic disorder	7.23e-06	4.24e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HRAS—autistic disorder	7.07e-06	4.15e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IL6—autistic disorder	6.92e-06	4.06e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HRAS—autistic disorder	6.92e-06	4.06e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IL6—autistic disorder	6.77e-06	3.97e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IL6—autistic disorder	6.62e-06	3.88e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PTEN—autistic disorder	6.49e-06	3.81e-05	CbGpPWpGaD
